H110172—Pathology

Contact:

Mentor: Yi-Ping Li, Ph.D., Jay McDonald Endowed Professor, Department of Pathology, Senior Vice Director for Research, UAB Center for Metabolic Bone Disease, University of Alabama at Birmingham (UAB), Shelby Biomedical Research Building, Room 810, 1825 University Blvd, Birmingham AL 35294-2182, Office (205) 975-2606, Lab (205) 975-2605, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. , Web page: http://pathuab.infomedia.com/faculty2.asp


We are seeking a full-time Postdoctoral Fellow in support of developmental and skeletal genetics investigations in the Department of Pathology, University of Alabama at Birmingham (UAB). The position for Postdoctoral Fellow is for the study of the mechanisms of skeletal development and diseases (see Nature Genetics, 23(4): 447-451; Hum. Mol. Genet, 16(4):410-423; Genes Dev, 21(14): 1803-1816) or the mechanisms of mammalian embryonic development and diseases (see Development, 130(7): 1367-79; Dev. Biol, 295(1): 116-127). Self-motivated individuals trained in any area of biomedical sciences are encouraged to apply. Please visit our lab website: http://pathuab.infomedia.com/faculty2.asp

http://bioinformatics.forsyth.org/ypli/index.html to learn more about our lab.

Please email your cover letter, resume/CV, and contact information for three references, toThis email address is being protected from spambots. You need JavaScript enabled to view it.  .


UAB News

  • As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.

  • effrey R. Curtis, M.D., from the University of Alabama at Birmingham, and colleagues utilized 1998 to 2011 data from the U.S. Veterans Health Administration to identify RA patients initiating rituximab, abatacept, or anti-tumor necrosis factor (anti-TNF) therapy. The authors sought to assess the comparative risk of hospitalized infection associated with anti-TNF and non-anti-TNF biologic agents.

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...